C4 Therapeutics (CCCC) EBT Margin Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2,817.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,558.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -683.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,688.00 |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - | -4,480.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,480.00 |
| Dec 31, 2025 | 48,042.00 |
| Sep 30, 2025 | -12,586.00 |
| Jun 30, 2025 | -25,504.00 |
| Mar 31, 2025 | 56,957.00 |
| Dec 31, 2024 | 39,196.00 |
| Sep 30, 2024 | 7,457.00 |
| Jun 30, 2024 | 120,086.00 |
| Mar 31, 2024 | -799.00 |
| Dec 31, 2023 | 24,566.00 |
| Sep 30, 2023 | 23,804.00 |
| Jun 30, 2023 | -115,413.00 |
| Mar 31, 2023 | -51,213.00 |
| Dec 31, 2022 | -122,492.00 |
| Sep 30, 2022 | -18,278.00 |
| Jun 30, 2022 | 3,657.00 |
| Mar 31, 2022 | -13,072.00 |
| Dec 31, 2021 | 18,731.00 |
| Sep 30, 2021 | -2,992.00 |
| Jun 30, 2021 | -11,751.00 |
| Mar 31, 2021 | -10,518.00 |
| Dec 31, 2020 | -14,203.00 |
| Sep 30, 2020 | -8,441.00 |